Pure Interstitial Trisomy 11q Arising from a Nonrecurrent 11q13.1q22.3 Mosaic Intrachromosomal Duplication in a Patient with Craniofacial Dysmorphism and Genital Anomalies

被引:0
作者
Anaya, Daniel Martinez [1 ]
Juarez-Velazquez, Maria del Rocio [1 ]
Ruvalcaba, Sinuhe Reyes [2 ]
Navarrete-Meneses, Maria del Pilar [1 ]
Labadia, Consuelo Salas [1 ]
Hernandez, Esther Lieberman [2 ]
Perez-Vera, Patricia [1 ]
机构
[1] Natl Pediat Inst, Genet & Canc Lab, Mexico City, Mexico
[2] Natl Pediat Inst, Dept Human Genet, Mexico City, Mexico
关键词
Intrachromosomal duplication; Pure interstitial trisomy 11q; Dosage-sensitive genes; Craniofacial abnormalities; Genital anomalies; MOLECULAR CYTOGENETIC CHARACTERIZATION; HIGH BONE MASS; FGF3; CRANIOSYNOSTOSIS; PHENOTYPE; DOSAGE; FAMILY;
D O I
10.1159/000528472
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: The pure interstitial trisomy 11q11q23.2 is an uncommon genomic disorder associated with nonrecurrent intrachromosomal duplications. The phenotype is characterized by intellectual disability and craniofacial abnormalities. Given their uncommonness, a comprehensive genotype-phenotype correlation has not fully been defined. Case Presentation: We report the clinical and cytogenomic characterization of a 5-year-old boy with intellectual disability, psychomotor retardation, craniofacial dysmorphism, genital anomalies, and pure interstitial trisomy 11q arising from a nonrecurrent 11q13.1q22.3 intrachromosomal duplication in a high-mosaic state (>80%). The duplicated chromosome was characterized by cytogenetics, multicolor banding FISH, and SNP array. We demonstrated the wide mosaic distribution of the 11q duplication by interphase FISH in tissues from different embryonic germ layers. The duplication involves a copy number gain of 45.3 Mb containing 22 dosage-sensitive genes. We confirmed the overexpression of dosage-sensitive genes along the duplicated region using RT-qPCR. Discussion: Only 8 patients have been described. Our patient shares clinical features with previous reports but differs from them by the presence of genital anomalies. We provide a detailed clinical review and an accurate genotype-phenotype correlation and propose PC, NDUFV1, FGF3, FGF4, and DHCR7 as dosage-sensitive genes with a possible role in the clinical spectrum of our patient; however, expression changes of FGF3/4 were not detected since they must be regulated in a spatiotemporal way. This patient contributes to the accurate description of the pure interstitial trisomy 11q. Future reports could continue to delineate the description, considering the relationship between the chromosome segment and the genes involved.
引用
收藏
页码:310 / 321
页数:12
相关论文
共 24 条
  • [11] Increased FGF3 and FGF4 gene dosage is a risk factor for craniosynostosis
    Grillo, Lucia
    Greco, Donatella
    Pettinato, Rosa
    Avola, Emanuela
    Potenza, Nabor
    Castiglia, Lucia
    Spalletta, Angela
    Amata, Silvestra
    Di Benedetto, Daniela
    Luciano, Daniela
    Romano, Corrado
    Fichera, Marco
    [J]. GENE, 2014, 534 (02) : 435 - 439
  • [12] An 11q11-q13-3 duplication, including FGF3 and FGF4 genes, in a patient with syndromic multiple craniosynostoses
    Jehee, Fernanda S.
    Bertola, Debora R.
    Yelavarthi, Krishna K.
    Krepischi-Santos, Ana C. V.
    Kim, Chong
    Vianna-Morgante, Angela M.
    Vermeesch, Joris R.
    Passos-Bueno, Maria Rita
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (16) : 1912 - 1918
  • [13] A 7.5-Mb Duplication at Chromosome 11q21-11q22.3 Is Associated With a Novel Spastic Ataxia Syndrome
    Johnson, Janel O.
    Stevanin, Giovanni
    van de Leemput, Joyce
    Hernandez, Dena G.
    Arepalli, Sampath
    Forlani, Sylvie
    Zonozi, Reza
    Gibbs, J. Raphael
    Brice, Alexis
    Durr, Alexandra
    Singleton, Andrew B.
    [J]. MOVEMENT DISORDERS, 2015, 30 (02) : 262 - 266
  • [14] An autosomal dominant high bone mass phenotype in association with craniosynostosis in an extended family is caused by an LRP5 missense mutation
    Kwee, ML
    Balemans, W
    Cleiren, E
    Gille, JJP
    Van der Blij, F
    Sepers, JM
    Van Hul, W
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1254 - 1260
  • [15] Legius E, 1996, CLIN GENET, V49, P206
  • [16] Identification of a haplosufficient 3.6-Mb region in human chromosome 11q14.3→q21
    Li, L
    Moore, P
    Ngo, C
    Petrovic, V
    White, SM
    Northrop, E
    Ioannou, PA
    McKinlay Gardner, RJ
    Slater, HR
    [J]. CYTOGENETIC AND GENOME RESEARCH, 2002, 97 (3-4) : 158 - 162
  • [17] Mcgowan-Jordan J., 2020, ISCN 2020: An International System for Human Cytogenomic Nomenclature
  • [18] Mhanni Aizeddin A, 2021, JIMD Rep, V61, P42, DOI 10.1002/jmd2.12235
  • [19] Cholesterol-mediated Degradation of 7-Dehydrocholesterol Reductase Switches the Balance from Cholesterol to Vitamin D Synthesis
    Prabhu, Anika V.
    Luu, Winnie
    Sharpe, Laura J.
    Brown, Andrew J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (16) : 8363 - 8373
  • [20] FGF/FGFR signaling in health and disease
    Xie, Yangli
    Su, Nan
    Yang, Jing
    Tan, Qiaoyan
    Huang, Shuo
    Jin, Min
    Ni, Zhenhong
    Zhang, Bin
    Zhang, Dali
    Luo, Fengtao
    Chen, Hangang
    Sun, Xianding
    Feng, Jian Q.
    Qi, Huabing
    Chen, Lin
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)